Kelly J - Search Results

1

Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep.

Chaplin PJ, De Rose R, Boyle JS, McWaters P, Kelly J, Tennent JM, Lew AM, Scheerlinck JP. Chaplin PJ, et al. Among authors: kelly j. Infect Immun. 1999 Dec;67(12):6434-8. doi: 10.1128/IAI.67.12.6434-6438.1999. Infect Immun. 1999. PMID: 10569760 Free PMC article.

2

The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy.

Scheerlinck JP, Casey G, McWaters P, Kelly J, Woollard D, Lightowlers MW, Tennent JM, Chaplin PJ. Scheerlinck JP, et al. Among authors: kelly j. Vaccine. 2001 Jul 16;19(28-29):4053-60. doi: 10.1016/s0264-410x(01)00133-5. Vaccine. 2001. PMID: 11427282

3

Capture of chromosomal DNA by anti-histone antibodies for PCR.

Lew AM, Kelly J. Lew AM, et al. Among authors: kelly j. Nucleic Acids Res. 1991 Jun 25;19(12):3459. doi: 10.1093/nar/19.12.3459. Nucleic Acids Res. 1991. PMID: 2062663 Free PMC article.

4

Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant.

Kelly JM, Sterry SJ, Cose S, Turner SJ, Fecondo J, Rodda S, Fink PJ, Carbone FR. Kelly JM, et al. Eur J Immunol. 1993 Dec;23(12):3318-26. doi: 10.1002/eji.1830231239. Eur J Immunol. 1993. PMID: 8258346

5

Characterization of diverse primary herpes simplex virus type 1 gB-specific cytotoxic T-cell response showing a preferential V beta bias.

Cose SC, Kelly JM, Carbone FR. Cose SC, et al. Among authors: kelly jm. J Virol. 1995 Sep;69(9):5849-52. doi: 10.1128/JVI.69.9.5849-5852.1995. J Virol. 1995. PMID: 7543591 Free PMC article.

6

Vasopressin antisense peptide interactions with the V1 receptor.

Kelly JM, Trinder D, Phillips PA, Casley DJ, Kemp B, Mooser V, Johnston CI. Kelly JM, et al. Peptides. 1990 Jul-Aug;11(4):857-62. doi: 10.1016/0196-9781(90)90204-i. Peptides. 1990. PMID: 2146598

7

T cell receptor V alpha bias can be determined by TCR-contact residues within an MHC-bound peptide.

Sterry SJ, Kelly JM, Turner SJ, Carbone FR. Sterry SJ, et al. Among authors: kelly jm. Immunol Cell Biol. 1995 Feb;73(1):89-94. doi: 10.1038/icb.1995.14. Immunol Cell Biol. 1995. PMID: 7768549

8

Reduced V1 vasopressin binding in the rat nucleus solitarii after nodose ganglionectomy.

Phillips PA, Widdop RE, Chai SY, Kelly J, Mooser V, Trinder D, Johnston CI. Phillips PA, et al. Among authors: kelly j. Clin Exp Pharmacol Physiol. 1990 Apr;17(4):321-5. doi: 10.1111/j.1440-1681.1990.tb01328.x. Clin Exp Pharmacol Physiol. 1990. PMID: 2140739

9

[125I]-[d(CH2)5, Sar7]AVP: a selective radioligand for V1 vasopressin receptors.

Kelly JM, Abrahams JM, Phillips PA, Mendelsohn FA, Grzonka Z, Johnston CI. Kelly JM, et al. J Recept Res. 1989;9(1):27-41. doi: 10.3109/10799898909066043. J Recept Res. 1989. PMID: 2521670

10

Characterization of monoclonal antibodies to a rat liver vasopressin receptor.

Trinder D, Mooser V, Kelly JM, Phillips PA, Casley D, Johnston CI. Trinder D, et al. Among authors: kelly jm. Clin Exp Pharmacol Physiol. 1991 May;18(5):345-8. doi: 10.1111/j.1440-1681.1991.tb01460.x. Clin Exp Pharmacol Physiol. 1991. PMID: 1829665

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,755 results

Search Page

Filters